Real-world comparison of anti-CD20 therapies: efficacy, infections, and immune profiles in a German cohort

BackgroundThe use of anti-CD20 drugs has become a widespread therapeutic approach in systemic and central nervous system (CNS) neuroinflammation. Apart from the desired B-cell depletion, relevant dynamics of the humoral and cellular immune response occur. Despite the extensive utilization of these d...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Jakob Stögbauer, Moritz Bewarder, Linda Groß, Lorenz Thurner, Klaus Fassbender, Rebecca Urschel, Einar A. Høgestøl, Gro O. Nygaard, Hanne F. Harbo, Olaf Stüve, Marc Pawlitzki, Sven G. Meuth, Martina Sester, Sergiu Groppa, Mathias Fousse
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2026-05-01
Schriftenreihe:	Frontiers in Immunology
Schlagworte:	B-cell depletion cellular immune status multiple sclerosis neuroimmunological diseases ocrelizumab ofatumumab
Online-Zugang:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1738865/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!